Venetoclax as a single agent and in combination with PI3K ‐MTOR1/2 kinase inhibitors against ibrutinib sensitive and resistant mantle cell lymphoma

Source: British Journal of Haematology - Category: Hematology Authors: Tags: Correspondence Source Type: research